Beximco Pharmaceuticals (FRA:R2WA) EPS (Basic) : €0.11 (TTM As of Sep. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Beximco Pharmaceuticals EPS (Basic)?

Beximco Pharmaceuticals's basic earnings per share (Basic EPS) for the three months ended in Sep. 2024 was €0.03. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was €0.11.

Beximco Pharmaceuticals's EPS (Diluted) for the three months ended in Sep. 2024 was €0.03. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was €0.11.

Beximco Pharmaceuticals's EPS without NRI for the three months ended in Sep. 2024 was €0.03. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was 0.11.

During the past 12 months, Beximco Pharmaceuticals's average EPS without NRIGrowth Rate was 26.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was 4.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 12.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 16.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Beximco Pharmaceuticals's highest 3-Year average EPS without NRI Growth Rate was 27.40% per year. The lowest was -14.50% per year. And the median was 16.70% per year.

Beximco Pharmaceuticals EPS (Basic) Historical Data

The historical data trend for Beximco Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals EPS (Basic) Chart

Beximco Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

EPS (Basic)

Get a 7-Day Free Trial

0.06

0.09

0.08

0.10

Beximco Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EPS (Basic)	Get a 7-Day Free Trial															0.03	0.03	0.02	0.03	0.03

Beximco Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Beximco Pharmaceuticals's Basic EPS for the fiscal year that ended in Jun. 2024 is calculated as

Basic EPS (A: Jun. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(45.919	-	0)	/	446.112
	=	0.10

Beximco Pharmaceuticals's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(13.238	-	0)	/	445.775
	=	0.03

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.11

Beximco Pharmaceuticals (FRA:R2WA) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Beximco Pharmaceuticals EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Beximco Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (FRA:R2WA) » Definitions » EPS (Basic)

Traded in Other Exchanges

BXP:UK BXPHARMA:Bangladesh

Address

19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205

Website

https://www.beximcopharma.com

Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Beximco Pharmaceuticals Headlines

No Headlines